Product Description

🔹 Product Overview
Erlocip 150 mg Tablet is a prescription anticancer medicine used for the treatment of certain types of cancers, including non-small cell lung cancer (NSCLC) and pancreatic cancer in specific treatment combinations.
It contains Erlotinib 150 mg, a targeted therapy medicine that belongs to the tyrosine kinase inhibitor (TKI) class. It works by blocking signals that help cancer cells grow and multiply.

🔹 Key Uses
• Treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations as advised by an oncologist
• Used in certain cases of pancreatic cancer along with other chemotherapy medicines
• Helps slow the growth and spread of cancer cells
• Used as part of targeted cancer therapy under specialist supervision

🔹 Composition
• Active ingredient: Erlotinib 150 mg
• Belongs to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor class
• Targeted anticancer medicine used in oncology treatment

🔹 How It Works
Erlocip 150 mg works by blocking the activity of the EGFR tyrosine kinase enzyme, which plays a role in cancer cell growth and division. By reducing these growth signals, erlotinib helps slow down the progression and multiplication of certain cancer cells.

🔹 Key Benefits
• Targeted treatment approach for suitable cancer patients
• Helps inhibit cancer cell growth signals
• Used in patients with specific tumor characteristics
• May help delay disease progression when effective
• Supports personalized cancer therapy plans under oncologist guidance

🔹 Dosage and Administration
• Take only as prescribed by an oncologist or healthcare professional
• Usually taken once daily on an empty stomach, as directed
• Swallow the tablet whole with water
• Do not change the dose or stop treatment without medical advice
• Regular monitoring may be required during therapy

🔹 Possible Side Effects
Possible side effects may include:
• Skin rash
• Diarrhea
• Loss of appetite
• Nausea or vomiting
• Fatigue
• Dry skin
• Mouth sores
Serious side effects may include lung inflammation, severe skin reactions, or liver problems. Seek immediate medical attention if severe symptoms occur.

🔹 Precautions
• Use only under the supervision of an oncologist
• Inform your doctor about liver problems, lung disease, or other medical conditions
• Avoid smoking, as it may affect erlotinib effectiveness
• Inform your healthcare provider about all medicines, supplements, and herbal products being used
• Avoid pregnancy during treatment unless advised by a specialist
• Regular blood tests and medical follow-up may be required